![NBD-H (=4-Hydrazino-7-nitro-2,1,3-benzoxadiazole Hydrazine) [for HPLC Labeling]](https://static.cymitquimica.com/products/3D/img/GFA46787.png "Click to enlarge")
NBD-H (=4-Hydrazino-7-nitro-2,1,3-benzoxadiazole Hydrazine) [for HPLC Labeling]
CAS: 131467-87-3
Ref. 3D-GFA46787
| 1g | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Product Information
- 2,1,3-Benzoxadiazole, 4-hydrazino-7-nitro-, compd. with hydrazine (1:1)
- 2,1,3-Benzoxadiazole, 4-hydrazinyl-7-nitro-, compd. with hydrazine (1:1)
- 4-Hydrazino-7-Nitro-2,1,3-Benzoxadiazole - Hydrazine (1:1)
- 4-Hydrazino-7-Nitro-2,1,3-Benzoxadiazole Hydrazine
- Benzofurazan, 4-hydrazino-7-nitro-, compd. with hydrazine (1:1)
- Hydrazine, compd. with 4-hydrazino-7-nitro-2,1,3-benzoxadiazole (1:1)
- Hydrazine, compd. with 4-hydrazino-7-nitrobenzofurazan (1:1)
- Hydrazinonitrobenzoxadiazolehydrazine
NBD-H is a carbonyl group labeling reagent that can be used for the detection of leukoderma. It reacts with amino, hydroxyl, and carboxylic acid groups in proteins to produce a variety of reaction products. NBD-H has been shown to cause renal toxicity in rats when administered intravenously. The reaction rate is temperature dependent and increases with increasing pH. Trifluoroacetic acid (TFA) is typically used as the solvent for the labeling reaction. TFA reacts with NBD-H to form the reactive intermediate trifluoroacetoamide, which reacts with protein amine groups to produce an NBD derivative that absorbs light at 400 nm or greater. This product can be used for reversed-phase high-performance liquid chromatography (HPLC).
Chemical properties
Technical inquiry about: 3D-GFA46787 NBD-H (=4-Hydrazino-7-nitro-2,1,3-benzoxadiazole Hydrazine) [for HPLC Labeling]
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
